261 related articles for article (PubMed ID: 22102891)
1. Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.
Chougule MB; Patel A; Sachdeva P; Jackson T; Singh M
PLoS One; 2011; 6(11):e27394. PubMed ID: 22102891
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.
Jackson T; Chougule MB; Ichite N; Patlolla RR; Singh M
Cancer Chemother Pharmacol; 2008 Dec; 63(1):117-26. PubMed ID: 18338172
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
Chougule MB; Patel AR; Jackson T; Singh M
PLoS One; 2011 Mar; 6(3):e17733. PubMed ID: 21423660
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.
Chougule M; Patel AR; Sachdeva P; Jackson T; Singh M
Lung Cancer; 2011 Mar; 71(3):271-82. PubMed ID: 20674069
[TBL] [Abstract][Full Text] [Related]
5. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer.
Hatami E; Nagesh PKB; Jaggi M; Chauhan SC; Yallapu MM
Eur J Pharmacol; 2020 Dec; 888():173486. PubMed ID: 32805254
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model.
Zhou S; Yang Y; Yang Y; Tao H; Li D; Zhang J; Jiang G; Fang J
PLoS One; 2013; 8(7):e68589. PubMed ID: 23874680
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine.
Bocci G; Danesi R; Marangoni G; Fioravanti A; Boggi U; Esposito I; Fasciani A; Boschi E; Campani D; Bevilacqua G; Mosca F; Del Tacca M
Eur J Pharmacol; 2004 Sep; 498(1-3):9-18. PubMed ID: 15363970
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy.
Casneuf VF; Demetter P; Boterberg T; Delrue L; Peeters M; Van Damme N
Oncol Rep; 2009 Jul; 22(1):105-13. PubMed ID: 19513511
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer.
Awasthi N; Zhang C; Ruan W; Schwarz MA; Schwarz RE
PLoS One; 2012; 7(6):e38477. PubMed ID: 22723862
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].
Tang CH; Liu XQ; Yang SF; Zhu B; Gao HJ
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):808-12. PubMed ID: 19173823
[TBL] [Abstract][Full Text] [Related]
11. Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma.
Feng F; Wang B; Sun X; Zhu Y; Tang H; Nan G; Wang L; Wu B; Huhe M; Liu S; Diao T; Hou R; Zhang Y; Zhang Z
Cancer Biol Ther; 2017 Jan; 18(1):51-62. PubMed ID: 28055291
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.
Zhang Y; Zhang H; Chen J; Zhao H; Zeng X; Zhang H; Qing C
Invest New Drugs; 2012 Feb; 30(1):8-16. PubMed ID: 20711631
[TBL] [Abstract][Full Text] [Related]
13. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
Zhang R; Ru Y; Gao Y; Li J; Mao S
Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
[TBL] [Abstract][Full Text] [Related]
14. EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer.
Schwarz RE; Awasthi N; Konduri S; Cafasso D; Schwarz MA
Ann Surg Oncol; 2010 May; 17(5):1442-52. PubMed ID: 20041350
[TBL] [Abstract][Full Text] [Related]
15. Potent effect of adenoviral vector expressing short hairpin RNA targeting ribonucleotide reductase large subunit M1 on cell viability and chemotherapeutic sensitivity to gemcitabine in non-small cell lung cancer cells.
Tokunaga Y; Liu D; Nakano J; Zhang X; Nii K; Go T; Huang CL; Yokomise H
Eur J Cancer; 2015 Nov; 51(16):2480-9. PubMed ID: 26254808
[TBL] [Abstract][Full Text] [Related]
16. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
17. Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.
Giovannetti E; Mey V; Danesi R; Basolo F; Barachini S; Deri M; Del Tacca M
Br J Cancer; 2005 Feb; 92(4):681-9. PubMed ID: 15700043
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction of hyperthermia and Gemcitabine in lung cancer.
Vertrees RA; Das GC; Popov VL; Coscio AM; Goodwin TJ; Logrono R; Zwischenberger JB; Boor PJ
Cancer Biol Ther; 2005 Oct; 4(10):1144-53. PubMed ID: 16138007
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
Bruns CJ; Harbison MT; Davis DW; Portera CA; Tsan R; McConkey DJ; Evans DB; Abbruzzese JL; Hicklin DJ; Radinsky R
Clin Cancer Res; 2000 May; 6(5):1936-48. PubMed ID: 10815919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
